Status:
COMPLETED
Screening in Myocardial Perfusion Patients
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
Gamma Medica-Ideas
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-90 years
Brief Summary
To expand the understanding of the uptake and distribution of Tc-99m sestamibi in the breast in a normal female population undergoing myocardial perfusion imaging using Molecular Breast Imaging (MBI).
Detailed Description
You are being asked to take part in this research study because you have been scheduled to have a scan of your heart. The radioactive dye used to image your heart is also taken up by many types of bre...
Eligibility Criteria
Inclusion
- They have had a mammogram at Mayo Clinic Rochester within the last 12 months
- Undergoing myocardial perfusion imaging
Exclusion
- They are unable to understand and sign the consent form
- They are physically unable to sit upright and still for 20 minutes
- They have undergone breast surgery or breast biopsy within the last 12 months.
- They have had trauma to the breast tissue or undergone radiation treatment to the breast within the last 12 months.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
322 Patients enrolled
Trial Details
Trial ID
NCT00943241
Start Date
July 1 2008
End Date
June 1 2010
Last Update
February 13 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905